VANESSA JARRETT: Open Payments
NPI 1639847445 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,210 in 130 payments from 16 companies in 2025. Trend: 2023 $2,030 · 2024 $2,176 · 2025 $2,210
Food & beverage: $2,210
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 34 | $409 |
| UCB, Inc. | 20 | $373 |
| GlaxoSmithKline, LLC. | 21 | $349 |
| PFIZER INC. | 15 | $243 |
| E.R. Squibb & Sons, L.L.C. | 9 | $198 |
| Novartis Pharmaceuticals Corporation | 8 | $152 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| ABBVIE INC. | 3 | $78 |
| GENZYME CORPORATION | 3 | $72 |
| CSL Behring | 3 | $63 |
Products named: Bimzelx, ORENCIA, XELJANZ, BENLYSTA, OTEZLA, NUCALA, COSENTYX, SAPHNELO.
Industry payments across MO — which companies pay providers there.
